GLOBAL STEM CELL MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL STEM CELL MARKET FORECAST 2019-2027

GLOBAL STEM CELL MARKET FORECAST 2019-2027

The global stem cell market was valued at $8731.01 million in 2018 & is estimated to generate net revenue of approximately $19747.56 million by 2027, growing at a CAGR of 9.50%.Stem cells have the potential to develop into different types of cells in the body. They serve as a repair system for the body.

GLOBAL STEM CELL MARKET FORECAST 2019-2027

Global Stem Cell Market by Products (Adult Stem Cell Market, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell Market, Rat Neural Stem Cell Market) by Technology (Stem Cell Acquisition, Stem Cell Production, Stem Cell Cryopreservation, Stem Cell Expansion and Sub-culture) by Application (Regenerative Medicine, Drug Discovery and Development) by Therapeutic Application (Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Diabetes, Injuries and Wounds, Cardiovascular Disorders, Other Therapeutic Applications) by Treatment Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy, Syngeneic Stem Cell Therapy) by Geography.

Request free sample

The global stem cell market was valued at $8731.01 million in 2018 & is estimated to generate net revenue of approximately $19747.56 million by 2027, growing at a CAGR of 9.50%. Stem cells have the potential to develop into different types of cells in the body. They serve as a repair system for the body. The stem cell market is primarily driven by the following factors:

  • Potential of stem cells in regenerative medicine
  • Key to anti-aging and prolonging life
  • Increasing R&D investments in adult stem cell research
  • Ease of administration
  • Reduced risk of tissue rejection in transplants
  • Federal funding for stem cell research
  • Rising awareness about umbilical cord stem cells
  • The rising number of clinical trials associated with stem cell research

The important drivers that are increasing the growth of the global Stem Cell market have been the potential of stem cells in Regenerative Medicine, and stem cell therapy being the key factor for anti-aging and prolonging lifespan. Regenerative medicine helps produce living, functional tissues to repair aged or diseased tissue; and is, thus, used in the treatment of cardiovascular, neural, orthopedic, and autoimmune diseases. Stem cell technology can replenish the body with young cells with the ability to divide, differentiate, and replace old and damaged cells.

Stem cell market product and therapeutic application are of wide usage. Adult stem cells are found in adult bone marrow and cord blood tissues. Adult stem cell therapy currently forms about 60% of the stem cell market and is also expected to have high growth potential. Embryonic stem cell technology is tied up with many ethical, political, and religious controversies, as the stem cells can be obtained only after the destruction of a human embryo. Induced Pluripotent Stem Cell is derivative from blood or skin cells that have been reprogrammed into an emergent-like pluripotent state that allows the growth of an unlimited source of any type of human cell needed for therapeutic purposes. Rat Neural Stem Cells (RNSC) is multipotent and can be induced to differentiate into neurons, astrocytes, and oligodendrocytes that make up the central nervous system (CNS). The therapy of neurological diseases using stem cells has been growing since the last two decades using embryonic stem cells, induced pluripotent stem cell, mesenchymal stem cells, and neural stem cells in general. Bone marrow transplant or stem cell transplant is a treatment for some kinds of tumor, like multiple myeloma, leukemia, neuroblastoma, multiple myeloma, or some types of lymphoma. Stem cells are evolving as a promising therapy for wounds with their unique properties of self-renewal and differentiation.

Safety issues and ethical issues are the major factors hindering the stem cell market. The safety issues concerning stem cells stored in banks need to be addressed to exploit the immense potential of stem cell therapy fully. The use of embryonic stem cells necessarily involves the destruction of the blastocyst and is thus considered a violation of human rights by those who believe that the embryo holds the right to life.

The global stem cell market segments include product, technology, application, therapeutic application, and treatment type.

Products are segmented into:

  • Adult stem cell market
    • Hematopoietic stem cell market
    • Mesenchymal stem cell market
    • Neural stem cell market
    • Dental stem cell market
    • Umbilical cord stem cell market
  • Human embryonic stem cell
  • Induced pluripotent stem cell market
  • Rat neural stem cell market

Technologies are segmented into:

  • Stem cell acquisition
    • Stem cell bone marrow market
    • Stem cell apheresis market
    • Umbilical cord blood market
  • Stem cell production
    • Therapeutic cloning
    • IVF stem cell
    • Stem cell culture
  • Stem cell cryopreservation
  • Stem cells expansion and sub-culture

Applications are segmented into:

  • Regenerative medicine
  • Drug discovery and development

Therapeutic applications are segmented into:

  • Orthopedic treatments
  • Neurological disorders
  • Injuries and wounds
  • Oncology disorders
  • Diabetes
  • Cardiovascular disorders
  • Other therapeutic applications

Treatment types are segmented into:

  • Syngeneic stem cell therapy
  • Allogeneic stem cell therapy
  • Autologic stem cell therapy

This report covers the present market conditions and the growth prospects of the global stem cell market for 2019-2027 and considered the revenue generated through the sales of stem cell market for products, technologies, and applications to calculate the market size by considering 2018 as the base year.

Geographically, the global stem cell market has been segmented on the basis of four major regions, which include:

The stem cell market in North America is expected to hold the largest share by 2027 due to the possibilities of the increased number of cancer cases in both males and females. North America held a share of approximately 37% in 2018. Also, increased investment in the Research and Development activities in the field of stem cell and other pharmaceuticals is also propelling the growth of the stem cell market in North America. The United States has apprehended the major share of the stem cell market in North America, and it is projected to be the fastest-growing market in the region.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the Stem Cell market. This can be attributed to the developing economies investing large amounts in medical research and healthcare facilities, coupled with the fact that there is an increase in incidences of chronic diseases like cancers. The stem cell market in the Asia Pacific will be one of the largest contributing markets in the near future.

The stem cell market is segmented based on Technologies which is sub-divided into Acquisition, Production, Cryopreservation, Expansion, and sub-culture, segmented on the basis of applications which is sub-divided into Regenerative medicine & Drug discovery and development and also segmented on the basis of Treatment type which is sub-divided into Autologic Stem Cell Therapy, Allogeneic Stem Cell Therapy and Syngeneic Stem Cell Therapy.

Stem cell acquisition is the process wherein stem cells are procured from mature tissues such as bone marrow, peripheral blood, and umbilical cord blood through bone marrow harvest, apheresis, and umbilical cord stem cell acquisition. Stem cell expansion and sub-culture involve growing the isolated cells in several flasks containing culture media. The growth in the stem cell applications market has been predominantly stimulated by the advent of regenerative medicines. Allogeneic stem cell therapy is used to treat sicknesses that destroy bone marrow, such as non-Hodgkin’s lymphoma, leukemia, multiple myeloma, and aplastic anemia. Autologic stem cell therapy is mainly used to treat certain types of leukemia, lymphomas, and multiple myeloma. Syngeneic stem cell therapy market, therefore, has very limited scope, despite its tremendous potential and would most likely remain such in the forecast period

The major market players of the global stem cell market are:

  • Becton Dickinson
  • GE Healthcare
  • Stemedica Cell Technologies Inc.
  • Corning Inc.
  • Thermo Fisher

Company Profiles covers the analysis of important players. Becton Dickinson Biosciences is a world leader in bringing innovative diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production and disease management. Thermo Fisher is a US-based company having headquarters in Massachusetts. The company has four business segments: laboratory products & services, analytical instruments, specialty diagnostics, and life sciences solutions.

Key Findings of the global stem cell market:

  • Regenerative medicine is the emerging branch of medical science
  • Use of adult stem cells has been significant
  • Induced pluripotent is the fastest growing stem cell product
  • Stem cell acquisition is the highest revenue-generating technology segment
  • Orthopedic treatments are the widely used stem-cell therapeutic application
  • Auto logic stem cell therapy treatment type is anticipated to grow significantly over the forecast period
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
    • ESTIMATION METHODOLOGY
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • REGENERATIVE MEDICINE IS THE EMERGING BRANCH OF MEDICAL SCIENCE
      • USE OF ADULT STEM CELL HAS BEEN SIGNIFICANT
      • INDUCED PLURIPOTENT IS THE FASTEST GROWING STEM CELL PRODUCT
      • STEM CELL ACQUISITION IS THE HIGHEST REVENUE GENERATING TECHNOLOGY SEGMENT
      • ORTHOPEDIC TREATMENTS IS THE WIDELY USED STEM CELL THERAPEUTIC APPLICATION
      • AUTOLOGIC STEM CELL THERAPY TREATMENT TYPE IS ANTICIPATED TO GROW SIGNIFICANTLY OVER THE FORECAST PERIOD
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVER
      • POTENTIAL OF STEM CELL IN REGENERATIVE MEDICINE
      • KEY TO ANTI-AGEING AND PROLONGING LIFE
      • INCREASING R&D INVESTMENTS IN ADULT STEM CELL RESEARCH
      • EASE OF ADMINISTRATION
      • REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
      • FEDERAL FUNDING FOR STEM CELL RESEARCH
      • RISING AWARENESS ABOUT UMBILICAL CORD STEM CELL
      • RISING NUMBER OF CLINICAL TRIALS ASSOCIATED WITH STEM CELL RESEARCH
    • MARKET RESTRAINTS
      • SAFETY ISSUES
      • ETHICAL ISSUES
      • HIGH COST ASSOCIATED WITH STEM CELL PROCEDURES
    • MARKET OPPORTUNITIES
      • TECHNOLOGICAL INNOVATIONS
      • EMERGING APPLICATION AS A DRUG DISCOVERY TOOL
      • OTHER PROMISING APPLICATIONS
    • MARKET CHALLENGES
      • STRINGENT GOVERNMENT REGULATIONS
      • LESS RESPONSIVENESS IN THE DEVELOPED ECONOMIES
      • LACK OF LEGISLATION
  1. MARKET BY PRODUCTS
    • ADULT STEM CELL MARKET
      • HEMATOPOIETIC STEM CELL MARKET
      • MESENCHYMAL STEM CELL MARKET
      • NEURAL STEM CELL MARKET
      • DENTAL STEM CELL MARKET
      • UMBILICAL CORD STEM CELL MARKET
    • HUMAN EMBRYONIC STEM CELL
    • INDUCED PLURIPOTENT STEM CELL MARKET
    • RAT NEURAL STEM CELL MARKET
  2. MARKET BY TECHNOLOGY
    • STEM CELL ACQUISITION
      • STEM CELL BONE MARROW MARKET
      • STEM CELL APHERESIS MARKET
      • UMBILICAL CORD BLOOD MARKET
    • STEM CELL PRODUCTION
      • THERAPEUTIC CLONING
      • IVF STEM CELL
      • STEM CELL CULTURE
    • STEM CELL CRYOPRESERVATION
    • STEM CELL EXPANSION AND SUB-CULTURE
  3. MARKET BY APPLICATION
    • REGENERATIVE MEDICINE
    • DRUG DISCOVERY AND DEVELOPMENT
  4. MARKET BY THERAPEUTIC APPLICATION
    • NEUROLOGICAL DISORDERS
    • ORTHOPEDIC TREATMENTS
    • ONCOLOGY DISORDERS
    • DIABETES
    • INJURIES AND WOUNDS
    • CARDIOVASCULAR DISORDERS
    • OTHER THERAPEUTIC APPLICATIONS
  5. MARKET BY TREATMENT TYPE
    • ALLOGENEIC STEM CELL THERAPY
    • AUTOLOGIC STEM CELL THERAPY
    • SYNGENEIC STEM CELL THERAPY
  6. KEY ANALYTICS
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • OPPORTUNITY MATRIX
    • KEY BUYING CRITERIA
      • HIGH PRICE
      • EFFICACY
      • APPLICATION AND EFFECTIVENESS
      • ACCURACY
    • STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
    • PEST ANALYSIS
    • HISTORY OF STEM CELL
    • PATENT ANALYSIS
      • STEM CELL PATENT IN NORTH AMERICA
      • STEM CELL PATENT IN EUROPE
      • STEM CELL PATENT IN ASIA PACIFIC
    • REGULATORY FRAMEWORK
  7. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC (APAC)
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD (ROW)
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILE
      • BECTON DICKINSON AND COMPANY
      • BIOTIME INC.
      • BRAINSTORM CELL THERAPEUTICS
      • CELGENE CORPORATION
      • CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
      • CELLULAR ENGINEERING TECHNOLOGIES, INC.
      • CORNING INC.
      • CYTORI THERAPEUTICS
      • FIBROCELL SCIENCE INC.
      • GE HEALTHCARE
      • INTERNATIONAL STEM CELL CORP.
      • STEMEDICA CELL TECHNOLOGIES INC.
      • STRYKER CORPORATION
      • TAKARA HOLDINGS INC.
      • THERMO FISHER
      • VERICEL CORPORATION (FORMERLY AASTROM BIOSCIENCE)
      • PLURISTEM THERAPEUTICS INC.
      • QIAGEN N.V.
      • STEMCELL TECHNOLOGIES

 

TABLE LIST

TABLE 1        GLOBAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        GLOBAL STEM CELL MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 3        GLOBAL STEM CELL MARKET IN ADULT STEM CELL BY REGION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL ADULT STEM CELL MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 5        GLOBAL HEMATOPOIETIC STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 6        GLOBAL MESENCHYMAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 7        GLOBAL NEURAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8        GLOBAL DENTAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 9        GLOBAL UMBILICAL CORD STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 10      GLOBAL HUMAN EMBRYONIC STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 11      GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 12      GLOBAL RAT NEURAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13      GLOBAL STEM CELL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 14      GLOBAL STEM CELL ACQUISITION MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 15      GLOBAL STEM CELL ACQUISITION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16      GLOBAL STEM CELL BONE MARROW MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 17      GLOBAL STEM CELL APHERESIS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 18      GLOBAL UMBILICAL CORD BLOOD MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19      GLOBAL STEM CELL PRODUCTION MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 20      GLOBAL STEM CELL PRODUCTION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 21      GLOBAL THERAPEUTIC CLONING MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 22      GLOBAL IVF STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 23      GLOBAL STEM CELL CULTURE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 24      GLOBAL STEM CELL CRYOPRESERVATION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 25      GLOBAL STEM CELL EXPANSION AND SUB-CULTURE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 26      GLOBAL STEM CELL MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 27      GLOBAL REGENERATIVE MEDICINE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 28      GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 29      GLOBAL STEM CELL MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 30      GLOBAL NEUROLOGICAL DISORDERS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 31      GLOBAL ORTHOPEDIC TREATMENTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 32      GLOBAL ONCOLOGY DISORDERS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 33      GLOBAL DIABETES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 34      GLOBAL INJURIES AND WOUNDS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 35      GLOBAL CARDIOVASCULAR DISORDERS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 36      GLOBAL OTHER THERAPEUTIC APPLICATIONS BACK BY REGION 2019-2027 ($ MILLION)

TABLE 37      GLOBAL STEM CELL MARKET BY TREATMENT TYPE 2019-2027 ($ MILLION)

TABLE 38      GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 39      GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 40      GLOBAL SYNGENEIC STEM CELL THERAPY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 41      GLOBAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 42      NORTH AMERICA STEM CELL MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

TABLE 43      EUROPE STEM CELL MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

TABLE 44      ASIA PACIFIC STEM CELL MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 45      STEM CELL RESEARCH POLICIES IN SOME ASIAN COUNTRIES

TABLE 46      REST OF WORLD STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

 

FIGURES LIST

FIGURE 1      GLOBAL STEM CELL MARKET 2019-2027 ($ MILLION)

FIGURE 2      GLOBAL ADULT STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

FIGURE 3      GLOBAL ADULT STEM CELL MARKET BY HEMATOPOIETIC STEM CELL 2019-2027 ($ MILLION)

FIGURE 4      GLOBAL ADULT STEM CELL MARKET BY MESENCHYMAL STEM CELL 2019-2027 ($ MILLION)

FIGURE 5      GLOBAL ADULT STEM CELL MARKET BY NEURAL STEM CELL 2019-2027 ($ MILLION)

FIGURE 6      GLOBAL ADULT STEM CELL MARKET BY DENTAL STEM CELL 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL ADULT STEM CELL MARKET BY UMBILICAL CORD STEM CELL 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL STEM CELL MARKET BY HUMAN EMBRYONIC STEM CELL 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL STEM CELL MARKET BY INDUCED PLURIPOTENT STEM CELL 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL STEM CELL MARKET BY RAT NEURAL STEM CELL 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL STEM CELL MARKET BY ACQUISITION 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL STEM CELL ACQUISITION MARKET BY BONE MARROW 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL STEM CELL ACQUISITION MARKET BY CELL APHERESIS 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL STEM CELL ACQUISITION MARKET BY UMBILICAL CORD BLOOD 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL STEM CELL MARKET BY PRODUCTION 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL STEM CELL PRODUCTION MARKET BY THERAPEUTIC CLONING 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL STEM CELL PRODUCTION MARKET BY IVF STEM CELL 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL STEM CELL PRODUCTION MARKET BY STEM CELL CULTURE 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL STEM CELL MARKET BY STEM CELL CRYOPRESERVATION 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL STEM CELL MARKET BY STEM CELL EXPANSION AND SUB-CULTURE 2019-2027 ($ MILLION)

FIGURE 21   GLOBAL STEM CELL MARKET BY REGENERATIVE MEDICINE 2019-2027 ($ MILLION)

FIGURE 22   GLOBAL STEM CELL MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL STEM CELL MARKET BY NEUROLOGICAL DISORDERS 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL STEM CELL MARKET BY ORTHOPEDIC TREATMENTS 2019-2027 ($ MILLION)

FIGURE 25   GLOBAL STEM CELL MARKET BY ONCOLOGY DISORDERS 2019-2027 ($ MILLION)

FIGURE 26   GLOBAL STEM CELL MARKET BY DIABETES 2019-2027 ($ MILLION)

FIGURE 27   GLOBAL STEM CELL MARKET BY INJURIES AND WOUNDS 2019-2027 ($ MILLION)

FIGURE 28   GLOBAL STEM CELL MARKET BY CARDIOVASCULAR DISORDERS 2019-2027 ($ MILLION)

FIGURE 29   GLOBAL STEM CELL MARKET BY OTHER THERAPEUTIC APPLICATIONS 2019-2027 ($ MILLION)

FIGURE 30   GLOBAL STEM CELL MARKET BY ALLOGENEIC STEM CELL THERAPY 2019-2027 ($ MILLION)

FIGURE 31   GLOBAL STEM CELL MARKET BY AUTOLOGIC STEM CELL THERAPY 2019-2027 ($ MILLION)

FIGURE 32   GLOBAL STEM CELL MARKET BY SYNGENEIC STEM CELL THERAPY 2019-2027 ($ MILLION)

FIGURE 33   GLOBAL STEM CELL MARKET SHARE BY REGION 2019-2027 (%)

FIGURE 34   THE UNITED STATES STEM CELL MARKET 2019-2027 (IN $ MILLION)

FIGURE 35   CANADA STEM CELL MARKET 2019-2027 (IN $ MILLION)

FIGURE 36   THE UNITED KINGDOM STEM CELL MARKET 2019-2027 (IN $ MILLION)

FIGURE 37   FRANCE STEM CELL MARKET 2019-2027 (IN $ MILLION)

FIGURE 38   GERMANY STEM CELL MARKET 2019-2027 (IN $ MILLION)

FIGURE 39   SPAIN STEM CELL MARKET 2019-2027 (IN $ MILLION)

FIGURE 40   ITALY STEM CELL MARKET 2019-2027 (IN $ MILLION)

FIGURE 41   REST OF EUROPE STEM CELL MARKET 2019-2027 (IN $ MILLION)

FIGURE 42   ASIA PACIFIC STEM CELL MARKET 2019-2027 ($ MILLION)

FIGURE 43   INDIA STEM CELL MARKET 2019-2027 ($ MILLION)

FIGURE 44   CHINA STEM CELL MARKET 2019-2027($ MILLION)

FIGURE 45   JAPAN STEM CELL MARKET 2019-2027 ($ MILLION)

FIGURE 46   AUSTRALIA STEM CELL MARKET 2019-2027 ($ MILLION)

FIGURE 47   SOUTH KOREA STEM CELL MARKET 2019-2027 ($ MILLION)

FIGURE 48   REST OF APAC STEM CELL MARKET 2019-2027($ MILLION)

FIGURE 49   REST OF WORLD STEM CELL MARKET 2019-2027 ($ MILLION)

FIGURE 50   LATIN AMERICA STEM CELL MARKET 2019-2027 ($ MILLION)

FIGURE 51   MIDDLE EAST & AFRICA STEM CELL MARKET 2019-2027 ($ MILLION)

FIGURE 52   STEM CELL MARKET SHARE ANALYSIS OF KEY PLAYERS 2018 (%)

  1. MARKET BY PRODUCTS
    • ADULT STEM CELL MARKET
      • HEMATOPOIETIC STEM CELL MARKET
      • MESENCHYMAL STEM CELL MARKET
      • NEURAL STEM CELL MARKET
      • DENTAL STEM CELL MARKET
      • UMBILICAL CORD STEM CELL MARKET
    • HUMAN EMBRYONIC STEM CELL
    • INDUCED PLURIPOTENT STEM CELL MARKET
    • RAT NEURAL STEM CELL MARKET
  2. MARKET BY TECHNOLOGY
    • STEM CELL ACQUISITION
      • STEM CELL BONE MARROW MARKET
      • STEM CELL APHERESIS MARKET
      • UMBILICAL CORD BLOOD MARKET
    • STEM CELL PRODUCTION
      • THERAPEUTIC CLONING
      • IVF STEM CELL
      • STEM CELL CULTURE
    • STEM CELL CRYOPRESERVATION
    • STEM CELL EXPANSION AND SUB-CULTURE
  3. MARKET BY APPLICATION
    • REGENERATIVE MEDICINE
    • DRUG DISCOVERY AND DEVELOPMENT
  4. MARKET BY THERAPEUTIC APPLICATION
    • NEUROLOGICAL DISORDERS
    • ORTHOPEDIC TREATMENTS
    • ONCOLOGY DISORDERS
    • DIABETES
    • INJURIES AND WOUNDS
    • CARDIOVASCULAR DISORDERS
    • OTHER THERAPEUTIC APPLICATIONS
  5. MARKET BY TREATMENT TYPE
    • ALLOGENEIC STEM CELL THERAPY
    • AUTOLOGIC STEM CELL THERAPY
    • SYNGENEIC STEM CELL THERAPY
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC (APAC)
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD (ROW)
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now